Pexidartinib hydrochloride
Pexidartinib hydrochloride (PLX-3397 HCl) is an orally bioavailable, ATP-competitive inhibitor targeting CSF1R (IC50=20 nM) and c-Kit (IC50=10 nM) . It induces apoptosis and is widely used in preclinical research to investigate tumor-associated macrophages and oncology in both in vitro and in vivo models.
Product Specifications
CAS Number
2040295-03-0
Product Name Alternative
PLX3397 hydrochloride, PLX-3397 hydrochloride
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.88% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble) ; DMSO:48 mg/mL (105.66 mM)
Smiles
Cl.FC (F) (F) C1=NC=C (C=C1) CNC2=NC=C (C=C2) CC3=CNC=4N=CC (Cl) =CC43
Molecular Formula
C20H16Cl2F3N5
Molecular Weight
454.28
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
500776 200 µg
HMGB2, GST-Tag, Recombinant (HMG2, High Mobility Group Protein B2) discontinued
Sign In for Pricing
View Details 310418-01 50 µg
CELSR3 (Cadherin EGF LAG Seven-pass G-type Receptor 3, Cadherin Family Member 11, Epidermal Growth Factor-like Protein 1, EGF-like Protein 1, Flamingo Homolog 1, hFmi1, Multiple Epidermal Growth Factor-like Domains Protein 2, Multiple EGF-like Domains Protein 2)
Sign In for Pricing
View Details 310418-02 100 µg
CELSR3 (Cadherin EGF LAG Seven-pass G-type Receptor 3, Cadherin Family Member 11, Epidermal Growth Factor-like Protein 1, EGF-like Protein 1, Flamingo Homolog 1, hFmi1, Multiple Epidermal Growth Factor-like Domains Protein 2, Multiple EGF-like Domains Protein 2)
Sign In for Pricing
View Details 